ACM Research, Inc.

step: "01" title: Business Model & Overview ticker: ACMR company: ACM Research, Inc. source: coverage-next-full date: 2026-06-03

Step 01 — Business Model & Overview: ACM Research, Inc. (ACMR)

1. Business Description

ACM Research, Inc. (Nasdaq: ACMR) designs, develops, manufactures, and sells semiconductor process equipment used by integrated circuit manufacturers. [S1] The company's core competency is single-wafer wet processing — the removal of contaminants, residues, and particles from semiconductor wafers during fabrication. Its tools are used at multiple critical points in the chip manufacturing process, from front-end-of-line (FEOL) logic and memory fabrication to advanced packaging. [S1][S2]

ACMR was founded in 1998 and IPO'd on Nasdaq in November 2017. The company operates primarily through ACM Research (Shanghai), Inc. ("ACM Shanghai"), a majority-owned subsidiary incorporated in China and publicly listed on the Shanghai STAR Market since 2019. [S1] This dual-listing structure creates a complex governance and capital structure but provides deep local market relationships, RMB access, and Chinese government alignment. [S3]

2. Value Chain Positioning

ACMR sits in the equipment vendor tier of the semiconductor value chain:

Raw materials / chemicals
         ↓
Semiconductor equipment OEMs  ← ACMR operates here
(AMAT, LRCX, TEL, SCREEN, KLAC, ACMR)
         ↓
Fab customers (IDMs + foundries)
(SMIC, HLMC, CXMT, SK Hynix, Intel)
         ↓
Fabless design / chip customers
(Qualcomm, Apple, Nvidia, etc.)
         ↓
OEMs / End consumers

ACMR's position: A specialized second-tier equipment OEM with dominant share in single-wafer wet cleaning within China, growing into electrochemical plating (ECP) and advanced packaging equipment. Not yet a full-suite fab equipment provider — competes on specific tool categories rather than full-fab outfitting. [S2][S7]

3. Product Portfolio

Product Family (the "Planetary Family" — branded April 2026): [S3]

Flagship: The Ultra C Tahoe single-wafer wet clean tool is the company's highest-margin, most differentiated product. It achieves 75% chemical reduction versus prior generation and controls particles down to 26nm. [S3] This is the key competitive differentiator versus SCREEN Holdings and legacy Western OEMs.

Revenue mix (estimated FY2025): [S2][S3]

• Single-wafer clean: ~65–70% of revenue
• ECP: ~15–20%
• Furnace / thermal: ~5–10%
• PECVD / Track / other: ~5–10% (Note: ACMR does not disclose exact product-level revenue split publicly)

4. Customer & Geographic Profile

Geographic concentration: [S1]

• Mainland China: ~99% of FY2025 revenue ($901M)
• International (SK Hynix, trial evaluations): <1%
• Oregon production facility under development for US-based customers (H2 2026 expected)

Top customers (estimated FY2025): [S7]

• HLMC (Hua Hong Microelectronics): ~15%
• SMIC (Semiconductor Manufacturing International): ~14%
• CXMT / memory fab successors: ~12% (YMTC entity successor context)
• Other China fabs: ~60%

Customer concentration: Top 3 customers ~41% of revenue; top 4 customers ~59% of receivables. [S7]

5. Revenue Model

Revenue recognition: Equipment revenue recognized upon delivery/acceptance of tools at the customer's fab. Service/support revenue (spare parts, maintenance) is smaller and recognized as delivered. [S1]

Ordering pattern: Multi-quarter lead times are typical. Customers place purchase orders 6–18 months in advance of expected tool delivery. This creates a backlog that provides near-term revenue visibility. [S3]

Pricing: Tool ASPs are not publicly disclosed. Based on comparable equipment in the sector, single-wafer clean tools typically price at $1M–$5M+ per unit depending on capability/node. ACMR competes on price versus SCREEN Holdings' higher ASPs. [S7]

6. Governance & Capital Structure

Dual-class share structure: [S5]

• Class A shares (NYSE): 1 vote/share — held by public investors
• Class B shares: 10 votes/share — held primarily by CEO David Wang
• CEO Wang controls 57.2% of voting power with only 14.4% economic interest

ACM Shanghai (STAR Market): ACMR holds ~70% of ACM Shanghai equity. The September 2025 private placement raised RMB 4.5B ($623M) at ACM Shanghai level, diluting ACMR's stake slightly and creating a $466M Non-Controlling Interest on the consolidated balance sheet. [S2] This capital is trapped at the Shanghai subsidiary level (subject to Chinese capital controls and SAFE regulations).

Summary balance sheet (FY2025 year-end): [S1][S2]

• Cash & equivalents: $1.17B (consolidated); Net cash attributable to ACMR: $845.5M
• Short-term borrowings: ~$120M
• Long-term debt: minimal
• NCI: $466M
• Total equity (ACMR-attributable): ~$1.05B

7. Strategic Positioning

Core thesis: ACMR is the beneficiary of China's semiconductor self-sufficiency policy (the "localization" mandate). Western equipment OEMs face escalating export controls under the BIS rules of Oct 2022, Oct 2023, and the December 2024 Entity List designation of ACM Shanghai. [S6] Meanwhile, China fabs (SMIC, HLMC, CXMT) have been directed to localize supply chains — creating an effectively captive market for ACMR within China. [S7]

International pivot: Management has set a long-term aspiration of generating "half revenue outside China." The most tangible proof point is the SK Hynix ECP/HBM order (>RMB 200M, Q3 2025). The Oregon manufacturing facility (opening H2 2026) is designed to serve US-based customers without involving ACM Shanghai (the Entity-Listed subsidiary). [S3]

Key tension: The very geopolitical dynamic that created ACMR's captive China market also limits its global addressability. Tools manufactured through ACM Shanghai cannot be easily exported to US allies. The Oregon facility is a structural workaround, but it starts small and faces a long ramp. [S3][S6]

Source Index

• [S1] SEC EDGAR XBRL + 10-K filings for ACMR (CIK 1680062)
• [S2] StockAnalysis.com financial statements and statistics
• [S3] ACM Research FY2025 10-K (filed 2026-03-02); Q4/FY2024 earnings press release
• [S4] Street consensus via Tavily WebSearch (June 2026)
• [S5] ACM Research DEF 14A proxy (filed April 29, 2025)
• [S6] BIS Entity List Federal Register notices (Dec 2024); BIS Oct 2022 / Oct 2023 rules
• [S7] Competitive intelligence: SCREEN Holdings, NAURA, Kerrisdale Capital thesis (Jan 2025)

step: "04" title: Financial Quality & Adversarial Sweep ticker: ACMR company: ACM Research, Inc. source: coverage-next-full date: 2026-06-03

Step 04 — Financial Quality & Adversarial Sweep: ACM Research, Inc. (ACMR)

1. Statement Quality Assessment

Revenue Recognition Quality: MODERATE-HIGH

ACMR recognizes revenue upon customer acceptance of tool deliveries. [S1] The business model (discrete equipment sales to identifiable customers under purchase orders) is relatively straightforward. Revenue cannot be easily manipulated through channel stuffing because fab customers are sophisticated, the verification process is rigorous, and the SEC EDGAR filing history shows consistent year-end reconciliations.

Watch point: China-based customers may have longer acceptance processes; some revenue recognition depends on customer sign-offs that could be delayed or front-loaded quarter-to-quarter. Quarterly variability is high (Q4 tends to be strongest, Q1 weakest). This is sector-normal and not a red flag. [S1]

Earnings Quality: MODERATE

[S1][S2] The FY2023 and FY2025 negative operating cash flows despite positive GAAP earnings are a concern. The culprit is working capital (inventory build) rather than earnings manipulation. FY2024 was the first year of genuine cash conversion ($141M OCF vs. $103.6M net income). FY2025 returned to negative OCF due to inventory pre-purchasing (Entity List response). [S3]

Assessment: Earnings are real but cash conversion is poor and lumpy. Not a fraud signal — this is structural to the business model. However, it means GAAP earnings overstate economic earnings in most years.

Balance Sheet Quality: MODERATE (complex)

The consolidation of ACM Shanghai creates complexity:

• $1.17B cash on consolidated balance sheet includes funds trapped at the Shanghai subsidiary level, subject to Chinese capital controls
• $845.5M net cash attributable to ACMR is the cleaner metric [S3]
• $466M NCI (non-controlling interest) from ACMSH September 2025 equity raise — dilutes economic ownership of ~$623M Shanghai cash
• $703M inventory is real but carries risk of obsolescence if customer delivery schedules slip

Adjustments to GAAP

2. Adversarial Research Sweep

Note: Transcript analysis was not performed (coverage-next-full path). Bear arguments sourced from published short theses, analyst reports, SEC disclosures, and press coverage.

Bear Thesis #1 — Kerrisdale Capital (January 2025): "Pattern Collapse at FinFET Nodes"

Source: Kerrisdale Capital published a long-form bear thesis on ACMR in January 2025. [S7]

Core claim: Kerrisdale argued that ACMR's cleaning technology is optimized for 28nm and older nodes. As China fabs attempt to push toward 7nm/5nm FinFET, the pattern density requires different cleaning physics — specifically, pattern collapse becomes a challenge for liquid-based wet cleaning. Kerrisdale suggested ACMR's tools may have a natural ceiling in advanced node capabilities.

Counter-evidence: The Ultra C Tahoe explicitly addresses <26nm particle control, and ACMR has announced supercritical CO2 clean tools for sub-10nm applications. The FY2026 product launch pipeline (Saturn PECVD, supercritical CO2) suggests R&D is ahead of the node transition. However, Kerrisdale's core point — that international fabs at 3nm/2nm nodes may not be addressable with ACMR tools — has not been fully rebutted. [S3]

Verdict: Partially valid for international expansion ambitions; less relevant for China-node market (28nm–14nm where ACMR is proven). Flag as a medium-term bear risk. [A01]

Bear Thesis #2 — BIS Entity List Escalation Risk

Source: Dec 2024 Federal Register; company 10-K risk factors. [S3][S6]

Core claim: ACM Shanghai was added to the Entity List in December 2024. The bear case argues: (1) the supply chain disruption is more severe than management admits, (2) the parent company ACMR could be added in subsequent rounds, and (3) Chinese customers may preemptively reduce ACMR tool purchases given the US government targeting signal.

Counter-evidence: FY2026 guidance reaffirmed at $1.08B–$1.18B. Management stated supply chain reorganization is "manageable." Q1 2026 shipment decline ($157M vs $245M prior year) appears partially Entity-List-driven, but H2 recovery expected based on backlog. [S3]

Verdict: The escalation tail risk is real and not fully priced. If ACMR parent (not just ACM Shanghai) is ever Entity Listed, the business faces an existential threat. Probability: low in the near term but non-zero given geopolitical direction. [A02]

Bear Thesis #3 — China Customer Credit Risk

Source: Kerrisdale Capital; sector analyst commentary. [S7]

Core claim: Some Chinese fab customers are operating with state support rather than commercial viability. If China's semiconductor buildout faces policy reversal or economic stress, customer payment risk increases. ACMR has ~$700M+ inventory partially destined for customers who might delay acceptance.

Counter-evidence: SMIC and HLMC are publicly listed companies with audited financials. CXMT (YMTC successor) is more opaque. ACMR does take credit risk on tools in work-in-progress, but the payment terms are largely secured by advance deposits and letters of credit for large orders.

Verdict: Moderate concern. Not an immediate catalyst but a tail risk in a Chinese economic stress scenario.

Bear Thesis #4 — Dual-Class Governance Discount

Source: DEF 14A; governance analysis. [S5]

Core claim: CEO David Wang controls 57.2% of votes with 14.4% economic stake. Minority shareholders have no effective governance recourse. Wang has been systematically selling shares ($59.9M over 24 months) via 10b5-1 plans, despite controlling the company.

Counter-evidence: Dual-class is common in tech/founder-led companies. Wang built the company from scratch and his interests are partially aligned (14.4% economic stake is still meaningful). The selling is programmatic and disclosed.

Verdict: Real governance risk but par for the course in founder-controlled tech companies. Represents a structural valuation discount vs. peers with clean governance.

No Fraud Allegations or SEC Investigation Found

A search of SEC enforcement actions, class action securities litigation, and short-seller reports found no allegations of revenue fabrication, undisclosed related-party transactions, or PCAOB audit failures for ACMR. [S1][S7] The HFCAA (Holding Foreign Companies Accountable Act) risk was referenced in prior years but PCAOB inspections of ACM Shanghai's auditor appear to have been completed satisfactorily.

3. Summary: Financial Quality Rating

Source Index

• [S1] SEC EDGAR XBRL + 10-K filings (CIK 1680062)
• [S2] StockAnalysis.com financial statements
• [S3] ACM Research FY2025 10-K (filed 2026-03-02)
• [S4] Street consensus via Tavily WebSearch
• [S5] DEF 14A proxy (April 2025)
• [S6] BIS Federal Register Entity List notices (Dec 2024)
• [S7] Kerrisdale Capital ACMR bear thesis (January 2025); competitive intelligence